Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3
Closed -$102K 1482
2019
Q3
$102K Sell
3
-4
-57% -$176K ﹤0.01% 1052
2019
Q2
$367K Sell
7
-5
-42% -$343K ﹤0.01% 942
2019
Q1
$1.03M Buy
12
+10
+500% +$692K 0.01% 655
2018
Q4
$134K Buy
+2
New +$177K ﹤0.01% 1032
2018
Q1
Sell
-11
Closed -$553K 1604
2017
Q4
$553K Buy
11
+4
+57% +$250K ﹤0.01% 1128
2017
Q3
$662K Buy
+7
New +$604K ﹤0.01% 1025

Other funds holding NCNA

Marshall Wace North America's NCNA Position: Q4 2019 in Review

Marshall Wace North America sold out of NuCana (NCNA) in Q4 2019, closing a stake of 3 shares — an estimated $102K sold.

Marshall Wace North America first reported a position in NCNA in Q3 2017 and held it in 6 quarters. The position peaked at $1.03M in Q1 2019. 20 funds tracked by Wall St. Rank hold NCNA as of Q4 2019.

  • Marshall Wace North America reported no remaining NuCana position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace North America sold 3 NuCana shares in Q4 2019, an estimated $102K.
  • Marshall Wace North America first reported a position in NuCana in Q3 2017 and held it in 6 quarters.
  • Marshall Wace North America's NuCana position peaked at $1.03M in Q1 2019.
  • 20 funds tracked by Wall St. Rank held NuCana as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.